BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 28587613)

  • 1. Prognostic value of plasma DPP4 activity in ST-elevation myocardial infarction.
    Li JW; Chen YD; Chen WR; You Q; Li B; Zhou H; Zhang Y; Han TW
    Cardiovasc Diabetol; 2017 Jun; 16(1):72. PubMed ID: 28587613
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma DPP4 activity is associated with no-reflow and major bleeding events in Chinese PCI-treated STEMI patients.
    Li JW; Chen YD; Chen WR; Jing J; Liu J; Yang YQ
    Sci Rep; 2016 Dec; 6():39412. PubMed ID: 28000723
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma dipeptidyl-peptidase-4 activity is associated with left ventricular systolic function in patients with ST-segment elevation myocardial infarction.
    Li JW; Chen YD; Liu YQ; Wang JD; Chen WR; Zhang YQ; Ma Q
    Sci Rep; 2017 Jul; 7(1):6097. PubMed ID: 28733630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discordant cardiac biomarker levels independently predict outcome in ST-segment elevation myocardial infarction.
    Leibundgut G; Gick M; Morel O; Ferenc M; Werner KD; Comberg T; Kienzle RP; Buettner HJ; Neumann FJ
    Clin Res Cardiol; 2016 May; 105(5):432-40. PubMed ID: 26563201
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation of Admission Heart Rate With Angiographic and Clinical Outcomes in Patients With Right Coronary Artery ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention: HORIZONS-AMI (The Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction) Trial.
    Kosmidou I; McAndrew T; Redfors B; Embacher M; Dizon JM; Mehran R; Ben-Yehuda O; Mintz GS; Stone GW
    J Am Heart Assoc; 2017 Jul; 6(7):. PubMed ID: 28724652
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MR-proADM as a Prognostic Marker in Patients With ST-Segment-Elevation Myocardial Infarction-DANAMI-3 (a Danish Study of Optimal Acute Treatment of Patients With STEMI) Substudy.
    Falkentoft AC; Rørth R; Iversen K; Høfsten DE; Kelbæk H; Holmvang L; Frydland M; Schoos MM; Helqvist S; Axelsson A; Clemmensen P; Jørgensen E; Saunamäki K; Tilsted HH; Pedersen F; Torp-Pedersen C; Kofoed KF; Goetze JP; Engstrøm T; Køber L
    J Am Heart Assoc; 2018 May; 7(11):. PubMed ID: 29776961
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of serum transaminases with short- and long-term outcomes in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Gao M; Cheng Y; Zheng Y; Zhang W; Wang L; Qin L
    BMC Cardiovasc Disord; 2017 Jan; 17(1):43. PubMed ID: 28129742
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plaque characteristics and inflammatory markers for the prediction of major cardiovascular events in patients with ST-segment elevation myocardial infarction.
    Her AY; Cho KI; Singh GB; An DS; Jeong YH; Koo BK; Shin ES
    Int J Cardiovasc Imaging; 2017 Oct; 33(10):1445-1454. PubMed ID: 28555389
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiac and Noncardiac Causes of Long-Term Mortality in ST-Segment-Elevation Acute Myocardial Infarction Patients Who Underwent Primary Percutaneous Coronary Intervention.
    Yamashita Y; Shiomi H; Morimoto T; Yaku H; Furukawa Y; Nakagawa Y; Ando K; Kadota K; Abe M; Nagao K; Shizuta S; Ono K; Kimura T;
    Circ Cardiovasc Qual Outcomes; 2017 Jan; 10(1):. PubMed ID: 28073848
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation and prognostic role of neutrophil to lymphocyte ratio and SYNTAX score in patients with acute myocardial infarction treated with percutaneous coronary intervention: A six-year experience.
    Zuin M; Rigatelli G; Picariello C; dell'Avvocata F; Marcantoni L; Pastore G; Carraro M; Nanjundappa A; Faggian G; Roncon L
    Cardiovasc Revasc Med; 2017 Dec; 18(8):565-571. PubMed ID: 28529092
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic implications of Q waves at presentation in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: An analysis of the HORIZONS-AMI study.
    Kosmidou I; Redfors B; Crowley A; Gersh B; Chen S; Dizon JM; Embacher M; Mehran R; Ben-Yehuda O; Mintz GS; Stone GW
    Clin Cardiol; 2017 Nov; 40(11):982-987. PubMed ID: 28696573
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differences in Short- and Long-Term Outcomes Among Older Patients With ST-Elevation Versus Non-ST-Elevation Myocardial Infarction With Angiographically Proven Coronary Artery Disease.
    Vora AN; Wang TY; Hellkamp AS; Thomas L; Henry TD; Goyal A; Roe MT
    Circ Cardiovasc Qual Outcomes; 2016 Sep; 9(5):513-22. PubMed ID: 27601458
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current characteristics and management of ST elevation and non-ST elevation myocardial infarction in the Tokyo metropolitan area: from the Tokyo CCU network registered cohort.
    Miyachi H; Takagi A; Miyauchi K; Yamasaki M; Tanaka H; Yoshikawa M; Saji M; Suzuki M; Yamamoto T; Shimizu W; Nagao K; Takayama M
    Heart Vessels; 2016 Nov; 31(11):1740-1751. PubMed ID: 26758733
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The prognostic impact of insulin resistance surrogates in patients with acute myocardial infarction with and without type 2 diabetes.
    Rokicka D; Hudzik B; Wróbel M; Stołtny T; Stołtny D; Nowowiejska-Wiewióra A; Rokicka S; Gąsior M; Strojek K
    Cardiovasc Diabetol; 2024 Apr; 23(1):147. PubMed ID: 38685054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Worsening atrioventricular conduction after hospital discharge in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: the HORIZONS-AMI trial.
    Kosmidou I; Redfors B; McAndrew T; Embacher M; Mehran R; Dizon JM; Ben-Yehuda O; Mintz GS; Stone GW
    Coron Artery Dis; 2017 Nov; 28(7):550-556. PubMed ID: 28644212
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of cardiac time intervals by tissue Doppler imaging M-mode in patients with acute ST-segment-elevation myocardial infarction treated with primary percutaneous coronary intervention.
    Biering-Sørensen T; Mogelvang R; Søgaard P; Pedersen SH; Galatius S; Jørgensen PG; Jensen JS
    Circ Cardiovasc Imaging; 2013 May; 6(3):457-65. PubMed ID: 23536267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Can we use plasma hyperosmolality as a predictor of mortality for ST-segment elevation myocardial infarction?
    Tatlisu MA; Kaya A; Keskin M; Uzman O; Borklu EB; Cinier G; Hayiroglu MI; Tatlisu K; Eren M
    Coron Artery Dis; 2017 Jan; 28(1):70-76. PubMed ID: 27608320
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The relationship between admission monocyte HDL-C ratio with short-term and long-term mortality among STEMI patients treated with successful primary PCI.
    Çiçek G; Kundi H; Bozbay M; Yayla C; Uyarel H
    Coron Artery Dis; 2016 May; 27(3):176-84. PubMed ID: 26751423
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ST-segment elevation on intracoronary electrocardiogram after percutaneous coronary intervention is associated with worse outcome in patients with non-ST-segment elevation myocardial infarction.
    Hishikari K; Kakuta T; Lee T; Murai T; Yonetsu T; Isobe M
    Catheter Cardiovasc Interv; 2016 Mar; 87(4):E113-21. PubMed ID: 26152334
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Presence of post-systolic shortening is an independent predictor of heart failure in patients following ST-segment elevation myocardial infarction.
    Brainin P; Haahr-Pedersen S; Sengeløv M; Olsen FJ; Fritz-Hansen T; Jensen JS; Biering-Sørensen T
    Int J Cardiovasc Imaging; 2018 May; 34(5):751-760. PubMed ID: 29230597
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.